• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学免疫学:工具开发与应用的最新进展

Chemical immunology: Recent advances in tool development and applications.

作者信息

Shi Yujie, Bashian Eleanor E, Hou Yingqin, Wu Peng

机构信息

Department of Molecular and Cellular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Department of Molecular and Cellular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

Cell Chem Biol. 2024 Mar 13. doi: 10.1016/j.chembiol.2024.02.006.

DOI:10.1016/j.chembiol.2024.02.006
PMID:38508196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11393185/
Abstract

Immunology was one of the first biological fields to embrace chemical approaches. The development of new chemical approaches and techniques has provided immunologists with an impressive arsenal of tools to address challenges once considered insurmountable. This review focuses on advances at the interface of chemistry and immunobiology over the past two decades that have not only opened new avenues in basic immunological research, but also revolutionized drug development for the treatment of cancer and autoimmune diseases. These include chemical approaches to understand and manipulate antigen presentation and the T cell priming process, to facilitate immune cell trafficking and regulate immune cell functions, and therapeutic applications of chemical approaches to disease control and treatment.

摘要

免疫学是最早采用化学方法的生物学领域之一。新化学方法和技术的发展为免疫学家提供了一系列令人瞩目的工具,以应对曾经被认为无法克服的挑战。本综述聚焦于过去二十年化学与免疫生物学交叉领域的进展,这些进展不仅在基础免疫学研究中开辟了新途径,还彻底改变了癌症和自身免疫性疾病治疗的药物研发。这些进展包括用于理解和操纵抗原呈递及T细胞启动过程、促进免疫细胞运输和调节免疫细胞功能的化学方法,以及化学方法在疾病控制和治疗中的应用。

相似文献

1
Chemical immunology: Recent advances in tool development and applications.化学免疫学:工具开发与应用的最新进展
Cell Chem Biol. 2024 Mar 13. doi: 10.1016/j.chembiol.2024.02.006.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians.1型糖尿病:临床医生自身免疫机制指南
Diabetes Obes Metab. 2025 May 15. doi: 10.1111/dom.16460.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Chemical Strategies to Modulate and Manipulate RNA Epigenetic Modifications.调控和操纵RNA表观遗传修饰的化学策略
Acc Chem Res. 2025 Jun 3;58(11):1727-1741. doi: 10.1021/acs.accounts.4c00844. Epub 2025 Mar 18.
9
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.由饮食信号驱动的表达T-bet的Tr1细胞主导小肠免疫格局。
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
10
Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.中枢神经系统罕见的非多发性硬化脱髓鞘疾病
Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):45. doi: 10.1007/s11910-025-01432-8.

本文引用的文献

1
Multiscale photocatalytic proximity labeling reveals cell surface neighbors on and between cells.多尺度光催化邻近标记揭示细胞表面上及细胞间的相邻细胞。
Science. 2024 Jul 19;385(6706):eadl5763. doi: 10.1126/science.adl5763.
2
The cancer-immunity cycle: Indication, genotype, and immunotype.癌症免疫周期:指征、基因型和免疫型。
Immunity. 2023 Oct 10;56(10):2188-2205. doi: 10.1016/j.immuni.2023.09.011.
3
Antibody-Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence.抗体药物偶联物:已批准药物及其临床证据水平综述
Cancers (Basel). 2023 Jul 30;15(15):3886. doi: 10.3390/cancers15153886.
4
Trimming Crystallizable Fragment (Fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies as Therapeutics.修剪结晶片段 (Fc) 聚糖可实现生物大分子作为治疗药物的直接酶法转移到抗体上。
Angew Chem Int Ed Engl. 2023 Sep 4;62(36):e202308174. doi: 10.1002/anie.202308174. Epub 2023 Jul 24.
5
Ru(bpy) -Enabled Cell-Surface Photocatalytic Proximity Labeling toward More Efficient Capture of Physically Interacting Cells.Ru(bpy) - 增强的细胞膜表面光催化邻近标记技术,用于更有效地捕获物理相互作用的细胞。
Angew Chem Int Ed Engl. 2023 Jul 10;62(28):e202303014. doi: 10.1002/anie.202303014. Epub 2023 Jun 6.
6
Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox.受体通过 E3 泛素连接酶招募进行消除(REULR):一种靶向蛋白质降解工具箱。
ACS Synth Biol. 2023 Apr 21;12(4):1081-1093. doi: 10.1021/acssynbio.2c00587. Epub 2023 Apr 3.
7
Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity.IL-2 与 IL-2Rα 的临近效应共价结合,选择性地激活调节性 T 细胞并抑制自身免疫。
Signal Transduct Target Ther. 2023 Jan 23;8(1):28. doi: 10.1038/s41392-022-01208-3.
8
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 T cells.BET 抑制剂通过增强白血病来源的终末耗竭 CD8 T 细胞中的 TCF7 可及性来挽救抗 PD-1 耐药性。
Leukemia. 2023 Mar;37(3):580-592. doi: 10.1038/s41375-023-01808-0. Epub 2023 Jan 21.
9
Use of intercellular proximity labeling to quantify and decipher cell-cell interactions directed by diversified molecular pairs.使用细胞间临近标记定量和解析由多样化分子对指导的细胞-细胞相互作用。
Sci Adv. 2022 Dec 21;8(51):eadd2337. doi: 10.1126/sciadv.add2337.
10
Suppression of Autoimmune Rheumatoid Arthritis with Hybrid Nanoparticles That Induce B and T Cell Tolerance to Self-Antigen.通过诱导B细胞和T细胞对自身抗原产生耐受性的混合纳米颗粒抑制自身免疫性类风湿关节炎
ACS Nano. 2022 Dec 27;16(12):20206-20221. doi: 10.1021/acsnano.2c05643. Epub 2022 Nov 23.